Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 432 of 1,261
  1. US 10610492

    Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications

    The Regents of the University of California · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  2. US 10610510

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  3. US 10610125

    Methods and compositions for cell-proliferation-related disorders

    Agios Pharmaceuticals, Inc. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  4. US 10610511

    Method of treatment

    VANDA PHARMACEUTICALS INC. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  5. WO 2020064693

    POLYTHÉRAPIE

    ADVANCED ACCELERATOR APPLICATIONS ITALY SRL [IT] · Granted Apr 2, 2020 · Expires Mar 28, 2040

    granted
  6. US 10603296

    Compositions and methods for diagnosis and treatment of neuromuscular disorders

    United States of America as represented by the Secretary of the Air Force · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  7. US 10604548

    Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  8. US 10604493

    Compositions, methods of use, and methods of treatment

    The Regents of the University of California · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  9. US 10603308

    Methods and compositions for treatment of epileptic disorders

    OVID THERAPEUTICS INC. · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  10. US 10604492

    CFTR regulators and methods of use thereof

    The Regents of the University of California · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  11. US 10604507

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  12. US 10603356

    Compositions and method for treatment of inflammatory bowel disease

    The Regents of the University of California · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  13. US 10604585

    Modulation of PTPRA to treat arthritis

    The Regents of the University of California · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  14. US 10604535

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  15. US 10603326

    Pharmaceutical formulation of 3α-ethynyl-3β-hydroxyandrostan-17-one oxime

    Umecrine Cognition AB · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  16. US 10604501

    Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  17. US 10603311

    Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

    The Board of Regents of the University of Texas System · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  18. US 10604806

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  19. US 10603153

    Hernia patch

    ATRIUM MEDICAL CORPORATION · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  20. US 10604582

    Anti-CD276 antibodies (B7H3)

    The United States of America, as represented by the Secretary, Department of Health · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  21. US 10604565

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Julius-Maximilians-Universitat Wurzburg · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  22. US 10604807

    Methods for diagnosing and assessing treatment for Cushing's syndrome

    Corcept Therapeutics Incorporated · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  23. US 10604537

    Solid state forms of ixazomib citrate

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  24. US 10604520

    N-acyl amino acid compounds and methods of use

    Pliant Therapeutics, Inc. · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.